Skip to main content

Skylight Health Group Inc(SLHG-X)
TSX Venture

Today's Change
Real-Time Last Update

Skylight Health Group: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (SLHG)

The Globe and Mail - Tue Nov 1, 2022

Skylight Health Group is now ranked among the top 10 undervalued stocks in the Healthcare sector on the TSX Venture Exchange. A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company. Valuation methodology provided by Stockcalc (see below). The healthcare sector contains companies in biotechnology, pharmaceuticals, hospitals, home and long-term care as well as related medical equipment manufacturers and suppliers.

All data provided as-at market close October 30, 2022. The list is sorted by stocks with the greatest percentage difference between valuation and price. Skylight Health Group Skylight Health Group Inc is a healthcare services and technology company, working to impact patient health outcomes. The company operates a US multi-state health network that comprises physical multi-disciplinary medical clinics providing a range of services from primary care, subspecialty, allied health and diagnostic testing. Skylight Health Group is listed under SLHG on the TSX Venture Exchange.



Close Price

Shares Outstanding



Cash per Share

Net Cash per Share

SLHG-XSkylight Health Group0.6100000
WAVE-XWaverley Pharma0.0400000
KNE-XKane Biotech0.0800000
HITI-XHigh Tide1.9800000
NLH-XNova Leap Health0.2700000
PAS-XPascal Biosciences0.0200000
ACST-XAcasti Pharma0.7600000
PINK-XPerimeter Medical Imaging1.4300000
THNK-XThink Research0.3600000
ROMJ-XRubicon Organics0.7200000

More about Skylight Health Group

Stocks in this category are held primarily for capital appreciation.

Artificial intelligence at Report on Business

Artificial Intelligence at Report on Business Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.